Evaluation of a multivalent vaccine against lymphatic filariasis in Rhesus macaque model

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Dakshinamoorthy, Gajalakshmi ^a   Von Gegerfelt, Agneta ^b   Andersen, Hanne ^b   Lewis, Mark ^b   Kalyanasundaram, Ramaswamy ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b BIOQUAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HELMINTH PROTEIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 10; MULTIVALENT FUSION PROTEIN VACCINE; PROTEIN ALT 2; SMALL HEAT SHOCK PROTEIN; TETRASPANIN; UNCLASSIFIED DRUG; VACCINE; HELMINTH ANTIBODY; IMMUNOGLOBULIN G; PARASITE ANTIGEN; PROTOZOAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BRUGIA MALAYI; CONTROLLED STUDY; CYTOKINE RESPONSE; DRUG EFFICACY; DRUG SAFETY; GERBIL; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; LARVA; LYMPHATIC FILARIASIS; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RHESUS MONKEY; VACCINATION; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; ELEPHANTIASIS, FILARIAL; EOSINOPHIL; IMMUNIZATION; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; MONONUCLEAR CELL;

MACACA MULATTA;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BRUGIA MALAYI; DISEASE MODELS, ANIMAL; ELEPHANTIASIS, FILARIAL; EOSINOPHILS; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MALE; PROTOZOAN VACCINES;

EID: 84912096614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112982     Document Type: Article

References (38)

1. Molyneux DH, Zagaria N (2002) Lymphatic filariasis elimination: Progress in global programme development. Ann Trop Med Parasitol 96 Suppl 2: S15-40.
2. Day KP (1991) The endemic normal in lymphatic filariasis: A static concept. Parasitol Today 7 (12) : 341-343.
3. Dakshinamoorthy G, Samykutty AK, Munirathinam G, Shinde GB, Nutman T, et al. (2012) Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis. PLoS One 7 (4) : E34077.
4. Veerapathran A, Dakshinamoorthy G, Gnanasekar M, Reddy MV, Kalyanasundaram R (2009) Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl Trop Dis 3 (6) : E457.
5. Gnanasekar M, Rao KV, He YX, Mishra PK, Nutman TB, et al. (2004) Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infect Immun 72 (8) : 4707-4715.
6. Anand SB, Gnanasekar M, Thangadurai M, Prabhu PR, Kaliraj P, et al. (2007) Immune response studies with Wuchereria bancrofti vespid allergen homologue (WbVAH) in human lymphatic filariasis. Parasitol Res 101 (4) : 981-988.
7. Thirugnanam S, Pandiaraja P, Ramaswamy K, Murugan V, Gnanasekar M, et al. (2007) Brugia malayi: Comparison of protective immune responses induced by Bm-Alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model. Exp Parasitol 116 (4) : 483-491.
8. Dakshinamoorthy G, Munirathinam G, Stoicescu K, Reddy MV, Kalyanasundaram R (2013) Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis. PLoS One 8 (10) : E77394.
9. Dakshinamoorthy G, Samykutty AK, Munirathinam G, Reddy MV, Kalyanasundaram R (2013) Multivalent fusion protein vaccine for lymphatic filariasis. Vaccine 31 (12) : 1616-1622.
10. Giambartolomei GH, Lasater BL, Villinger F, Dennis VA (1998) Diminished production of T helper 1 cytokines and lack of induction of IL-2R+ T cells correlate with T-cell unresponsiveness in rhesus monkeys chronically infected with Brugia malayi. Exp Parasitol 90 (1) : 77-85.
11. Gardner MB, Luciw PA (2008) Macaque models of human infectious disease. Ilar J 49 (2) : 220-255.
12. Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, et al. (2011) Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic. J Infect Dis 204 (9) : 1437-1449.
13. Shedlock DJ, Silvestri G, Weiner DB (2009) Monkeying around with HIV vaccines: Using rhesus macaques to define 'gatekeepers' for clinical trials. Nat Rev Immunol 9 (10) : 717-728.
14. el-Bihari S, Ewert A (1971) Distribution of developing and mature Brugia malayi in Rhesus monkeys and in the jird, Meriones unguiculatus, after a single infection. J Parasitol 57 (6) : 1170-1174.
15. Crandall RB, Crandall CA, Neilson JT, Fletcher JT, Kozek WW, et al. (1983) Antibody responses to experimental Brugia malayi infections in patas and rhesus monkeys. Acta Trop 40 (1) : 53-64.
16. Wong MM, Guest MF, Lim KC, Sivanandam S (1977) Experimental Brugia malayi infections in the rhesus monkey. Southeast Asian J Trop Med Public Health 8 (2) : 265-273.
17. Folse DS, Ewert A (1988) Edema resulting from experimental filariasis. Lymphology 21 (4) : 244-247.
18. Wong MM, Fredericks HJ, Ramachandran CP (1969) Studies on immunization against Brugia malayi infection in the rhesus monkey. Bull World Health Organ 40 (4) : 493-501.
19. Parish CR, Glidden MH, Quah BJ, Warren HS (2009) Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr Protoc Immunol Chapter 4: Unit4 9.
20. Liu JY1, Wang GQ, Chen YN, Tu ZP, Fang Z (1989) Observations on the clinical manifestations and treatment of an experimental infection with Brugia malayi in man. J Trop Med Hyg. 92 (2) : 93-96.
21. Mishra K, Raj DK, Dash AP, Hazra RK (2005) Combined detection of Brugia malayi and Wuchereria bancrofti using single PCR. Acta Trop 93 (3) : 233-237.
22. Rao RU, Weil GJ, Fischer K, Supali T, Fischer P (2006) Detection of Brugia parasite DNA in human blood by real-Time PCR. J Clin Microbiol 44 (11) : 3887-3893.
23. Pearlman E, Kroeze WK, Hazlett FE Jr., Chen SS, Mawhorter SD, et al. (1993) Brugia malayi: Acquired resistance to microfilariae in BALB/c mice correlates with local Th2 responses. Exp Parasitol 76 (2) : 200-208.
24. Pearlman E, Kazura JW, Hazlett FE Jr., Boom WH (1993) Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol 151 (9) : 4857-4864.
25. Choi YJ, Ghedin E, Berriman M, McQuillan J, Holroyd N, et al. (2011) A deep sequencing approach to comparatively analyze the transcriptome of lifecycle stages of the filarial worm, Brugia malayi. PLoS Negl Trop Dis 5 (12) : E1409.
26. Farid HA, Hammad RE, Hassan MM, Ramzy RM, El Setouhy M, et al. (2005) Effects of combined diethylcarbamazine and albendazole treatment of bancroftian filariasis on parasite uptake and development in Culex pipiens L. Am J Trop Med Hyg 73 (1) : 108-114.
27. Critchley J, Addiss D, Ejere H, Gamble C, Garner P, et al. (2005) Albendazole for the control and elimination of lymphatic filariasis: Systematic review. Trop Med Int Health 10 (9) : 818-825.
28. Hotez PJ (2009) Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin Pharmacol Ther 85 (6) : 659-664.
29. Joseph SK, Ramaswamy K (2013) Single multivalent vaccination boosted by trickle larval infection confers protection against experimental lymphatic filariasis. Vaccine 31 (33) : 3320-3326.
30. Shearer MH, Dark RD, Chodosh J, Kennedy RC (1999) Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol 6 (6) : 953-958.
31. Jin BR, Kim SJ, Lee JM, Kang SH, Han HJ, et al. (2013) Alum Directly Modulates Murine B Lymphocytes to Produce IgG1 Isotype. Immune Netw 13 (1) : 10-15.
32. Dakshinamoorthy G, Kalyanasundaram R (2013) Evaluating the efficacy of rBmHATalphac as a multivalent vaccine against lymphatic filariasis in experimental animals and optimizing the adjuvant formulation. Vaccine 32 (1) : 19-25.
33. Turner P, Copeman B, Gerisi D, Speare R (1993) A comparison of the Og4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of Bancroftian filariasis. Trop Med Parasitol 44 (1) : 45-48.
34. de Almeida AB, Carmelita M, Silva Me, Maciel MAl, Freedman DO (1996) The Presence or Absence of Active Infection, Not Clinical Status, Is Most Closely Associated with Cytokine Responses in Lymphatic Filariasis. Journal of Infectious Diseases 173 (6) : 1453-1459.
35. Maizels RM, Sartono E, Kurniawan A, Partono F, Selkirk ME, et al. (1995) Tcell activation and the balance of antibody isotypes in human lymphatic filariasis. Parasitol Today 11 (2) : 50-56.
36. Mahanty S, Nutman TB (1995) Immunoregulation in human lymphatic filariasis: The role of interleukin 10. Parasite Immunol 17 (8) : 385-392.
37. Maizels RM, Holland MJ, Falcone FH, Zang XX, Yazdanbakhsh M (1999) Vaccination against helminth parasites-The ultimate challenge for vaccinologists? Immunol Rev 171: 125-147.
38. Mahanty S, Luke HE, Kumaraswami V, Narayanan PR, Vijayshekaran V, et al. (1996) Stage-specific induction of cytokines regulates the immune response in lymphatic filariasis. Exp Parasitol 84 (2) : 282-290.